Abstract
ObjectiveEvidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the pathogenesis of rheumatoid arthritis and osteoarthritis. The goal of the research was to evaluate the correlation between chronic pain and changes in the SP level in patients with chronic inflammation of the connective tissue.MethodsPatients with osteoarthritis and rheumatoid arthritis were enrolled in this study. The relationship between chronic pain intensity and the serum SP concentration was evaluated in these groups of patients with osteoarthritis and rheumatoid arthritis.ResultsThe results showed a positive correlation between the serum SP concentrations and chronic pain intensity.Conclusions1. The SP serum concentration was significantly different between the groups of patients with OA and RA. 2. There was a positive correlation between the serum SP concentration and chronic pain intensity in OA and RA patients.
Highlights
Von Euler and Gaddun discovered substance P (SP) in 1931 [1]
The results showed a positive correlation between the serum SP concentrations and chronic pain intensity
The SP serum concentration was significantly different between the groups of patients with OA and Rheumatoid arthritis (RA). 2
Summary
Evidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the pathogenesis of rheumatoid arthritis and osteoarthritis. The goal of the research was to evaluate the correlation between chronic pain and changes in the SP level in patients with chronic inflammation of the connective tissue. Data Availability Statement: All data are available in the paper.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have